SLFN11 is a putative DNA/RNA helicase that enhances the sensitivity of cancer cells to DNA-damaging agents, such as topoisomerase I/II inhibitors, alkylating agents like carboplatin and cisplatin, and DNA synthesis inhibitors such as gemcitabine (31). The gene discussed is SLFN11; the disease is cancer.